[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100576716":3},{"organization":4,"armGroups":7,"interventions":31,"overallOfficials":100,"centralContacts":104,"locations":110,"responsibleParty":594,"collaborators":70,"id":596,"slug":597,"hasResults":598,"nctId":599,"briefTitle":600,"officialTitle":601,"acronym":70,"eligibilityCriteria":602,"healthyVolunteers":598,"sex":603,"minAge":604,"maxAge":70,"enrollmentInfo":605,"targetDuration":70,"studyType":608,"phases":609,"briefSummary":611,"conditions":612,"keywords":614,"overallStatus":113,"whyStopped":70,"lastUpdateSubmitDate":618,"lastUpdatePostDateStruct":619,"startDateStruct":622,"completionDateStruct":624,"leadSponsor":626,"locationsCount":627},{"fullName":5,"class":6},"Merck Sharp & Dohme LLC","INDUSTRY",[8,20],{"label":9,"type":10,"description":11,"interventionNames":12},"Pembrolizumab + Platinum","ACTIVE_COMPARATOR","Neoadjuvant: Prior to surgery pembrolizumab 200 mg every three weeks (Q3W) for 4 cycles (each cycle is 21 days); Cisplatin 75 mg\u002Fm\\^2 Q3W with gemcitabine 1000 mg\u002Fm\\^2 on Day 1 and Day 8 Q3W (squamous tumors), pemetrexed 500 mg\u002Fm\\^2 Q3W (nonsquamous tumors), or paclitaxel 175 mg\u002Fm\\^2 or 200 mg\u002Fm\\^2 q3w (any histology) OR Carboplatin AUC 5 mg\u002FmL• min or AUC 6 mg\u002FmL• min with paclitaxel 175 mg\u002Fm\\^2 or 200 mg\u002Fm\\^2 Q3W (any histology), pemetrexed 500 mg\u002Fm\\^2 Q3W (nonsquamous tumors), or gemcitabine 1000 mg\u002Fm\\^2 on Day 1 and Day 8 Q3W (squamous tumors); followed by surgery.\n\nAdjuvant: After surgery pembrolizumab 200 mg Q3W for 13 cycles (each cycle is 21 days).",[13,14,15,16,17,18,19],"Biological: Pembrolizumab (neoadjuvant)","Drug: Cisplatin","Drug: Gemcitabine","Drug: Pemetrexed","Drug: Carboplatin","Biological: Pembrolizumab (adjuvant)","Drug: Paclitaxel",{"label":21,"type":22,"description":23,"interventionNames":24},"Pembrolizumab + Sacituzumab tirumotecan","EXPERIMENTAL","Neoadjuvant: Prior to surgery pembrolizumab 200 mg Q3W for 4 cycles (each cycle is 21 days); sacituzumab tirumotecan 4 mg\u002Fkg Q2W for 6 cycles (each cycle is 14 days), followed by surgery.\n\nAdjuvant: After surgery pembrolizumab 200 mg Q3W for 13 cycles (each cycle is 21 days). Optional adjuvant platinum-based doublet chemotherapy up to 4 cycles may be given at the investigator's discretion.",[13,14,15,16,25,26,27,28,29,17,18,19,30],"Drug: Sacituzumab tirumotecan","Drug: H1 receptor antagonist","Drug: H2 receptor antagonist","Drug: Acetaminophen (or equivalent)","Drug: Dexamethasone (or equivalent)","Drug: Steroid mouthwash (dexamethasone or equivalent)",[32,40,47,53,59,66,71,74,77,81,87,92,96],{"type":33,"name":34,"description":35,"armGroupLabels":36,"otherNames":37},"BIOLOGICAL","Pembrolizumab (neoadjuvant)","Before surgery neoadjuvant Pembrolizumab 200 mg by intravenous (IV) infusion on day 1 of each 21-day cycle for 4 cycles",[9,21],[38,39],"KEYTRUDA®","MK-3475",{"type":41,"name":42,"description":43,"armGroupLabels":44,"otherNames":45},"DRUG","Cisplatin","Cisplatin 75 mg\u002Fm\\^2 by IV infusion on day 1 of each 21-day cycle for 4 cycles",[9,21],[46],"PLATINOL®",{"type":41,"name":48,"description":49,"armGroupLabels":50,"otherNames":51},"Gemcitabine","In squamous tumors Gemcitabine 1000 mg\u002Fm\\^2 by IV infusion on day 1 and day 8 of each 21-day cycle for 4 cycles.",[9,21],[52],"GEMZAR®",{"type":41,"name":54,"description":55,"armGroupLabels":56,"otherNames":57},"Pemetrexed","In nonsquamous tumors Pemetrexed 500 mg\u002Fm\\^2 by IV infusion on day 1 of each 21-day cycle for 4 cycles",[9,21],[58],"Alimta®",{"type":41,"name":60,"description":61,"armGroupLabels":62,"otherNames":63},"Sacituzumab tirumotecan","Sacituzumab tirumotecan 4 mg\u002Fkg by IV infusion on day 1 of each 14-day cycle for up to 6 cycles",[21],[64,65],"MK-2870","SKB264",{"type":41,"name":67,"description":68,"armGroupLabels":69,"otherNames":70},"H1 receptor antagonist","Administered as rescue medication before Sacituzumab tirumotecan infusion per approved product label",[21],null,{"type":41,"name":72,"description":68,"armGroupLabels":73,"otherNames":70},"H2 receptor antagonist",[21],{"type":41,"name":75,"description":68,"armGroupLabels":76,"otherNames":70},"Acetaminophen (or equivalent)",[21],{"type":41,"name":78,"description":79,"armGroupLabels":80,"otherNames":70},"Dexamethasone (or equivalent)","Administered as rescue medication 8 -10 mg before Sacituzumab tirumotecan infusion per approved product label",[21],{"type":41,"name":82,"description":83,"armGroupLabels":84,"otherNames":85},"Carboplatin","AUC 5 mg\u002FmL min or AUC 6 mg\u002FmL min by IV infusion on day 1 of each 21-day cycle for 4 cycles",[9,21],[86],"PARAPLATIN®",{"type":33,"name":88,"description":89,"armGroupLabels":90,"otherNames":91},"Pembrolizumab (adjuvant)","After surgery adjuvant Pembrolizumab 200 mg by IV infusion on day 1 of each 21-day cycle for 13 cycles",[9,21],[38,39],{"type":41,"name":93,"description":94,"armGroupLabels":95,"otherNames":70},"Paclitaxel","Paclitaxel 175 or 200 mg\u002Fm\\^2 by IV infusion on day 1 of each 21-day cycle for 4 cycles.",[9,21],{"type":41,"name":97,"description":98,"armGroupLabels":99,"otherNames":70},"Steroid mouthwash (dexamethasone or equivalent)","Administered orally as rescue medication 2-5 mL 4 times daily",[21],[101],{"name":102,"affiliation":5,"role":103},"Medical Director","STUDY_DIRECTOR",[105],{"name":106,"role":107,"phone":108,"phoneExt":70,"email":109},"Toll Free Number","CONTACT","1-888-577-8839","Trialsites@msd.com",[111,129,142,155,168,181,194,206,219,234,243,252,267,276,285,298,313,326,338,353,365,374,386,401,414,427,441,454,466,478,490,502,517,530,543,556,569,582],{"facility":112,"status":113,"city":114,"state":115,"zip":116,"country":117,"countryCode":118,"cosmosGeoPoint":119,"geoPoint":124,"contacts":125},"Southern Cancer Center (SCC) ( Site 8004)","RECRUITING","Daphne","Alabama","36526","United States","US",{"type":120,"coordinates":121},"Point",[122,123],-87.9036,30.60353,{"lat":123,"lon":122},[126],{"name":127,"role":107,"phone":128,"phoneExt":70,"email":70},"Study Coordinator","251-607-5281",{"facility":130,"status":113,"city":131,"state":132,"zip":133,"country":117,"countryCode":118,"cosmosGeoPoint":134,"geoPoint":138,"contacts":139},"Sansum Clinic (Ridley Tree) ( Site 8012)","Santa Barbara","California","93105",{"type":120,"coordinates":135},[136,137],-119.69819,34.42083,{"lat":137,"lon":136},[140],{"name":127,"role":107,"phone":141,"phoneExt":70,"email":70},"805-879-0643",{"facility":143,"status":113,"city":144,"state":145,"zip":146,"country":117,"countryCode":118,"cosmosGeoPoint":147,"geoPoint":151,"contacts":152},"Rocky Mountain Cancer Centers (RMCC) ( Site 8011)","Lone Tree","Colorado","80124",{"type":120,"coordinates":148},[149,150],-104.8863,39.55171,{"lat":150,"lon":149},[153],{"name":127,"role":107,"phone":154,"phoneExt":70,"email":70},"303-285-5051",{"facility":156,"status":113,"city":157,"state":158,"zip":159,"country":117,"countryCode":118,"cosmosGeoPoint":160,"geoPoint":164,"contacts":165},"MedStar Franklin Square Medical Center ( Site 0033)","Baltimore","Maryland","21237",{"type":120,"coordinates":161},[162,163],-76.61219,39.29038,{"lat":163,"lon":162},[166],{"name":127,"role":107,"phone":167,"phoneExt":70,"email":70},"443-777-7147",{"facility":169,"status":113,"city":170,"state":171,"zip":172,"country":117,"countryCode":118,"cosmosGeoPoint":173,"geoPoint":177,"contacts":178},"Oncology Associates of Oregon, P.C.(Willamette Valley Cancer Institute) (WVCI) ( Site 8006)","Eugene","Oregon","97401",{"type":120,"coordinates":174},[175,176],-123.08675,44.05207,{"lat":176,"lon":175},[179],{"name":127,"role":107,"phone":180,"phoneExt":70,"email":70},"541-683-5001",{"facility":182,"status":113,"city":183,"state":184,"zip":185,"country":117,"countryCode":118,"cosmosGeoPoint":186,"geoPoint":190,"contacts":191},"Texas Oncology - Central\u002FSouth Texas ( Site 8009)","Austin","Texas","78705",{"type":120,"coordinates":187},[188,189],-97.74306,30.26715,{"lat":189,"lon":188},[192],{"name":127,"role":107,"phone":193,"phoneExt":70,"email":70},"254-399-0741",{"facility":195,"status":113,"city":196,"state":184,"zip":197,"country":117,"countryCode":118,"cosmosGeoPoint":198,"geoPoint":202,"contacts":203},"Texas Oncology - Northeast Texas ( Site 8005)","Tyler","75702",{"type":120,"coordinates":199},[200,201],-95.30106,32.35126,{"lat":201,"lon":200},[204],{"name":127,"role":107,"phone":205,"phoneExt":70,"email":70},"903-579-9800",{"facility":207,"status":113,"city":208,"state":209,"zip":210,"country":117,"countryCode":118,"cosmosGeoPoint":211,"geoPoint":215,"contacts":216},"Virginia Cancer Specialists (VCS) ( Site 8002)","Fairfax","Virginia","22031",{"type":120,"coordinates":212},[213,214],-77.30637,38.84622,{"lat":214,"lon":213},[217],{"name":127,"role":107,"phone":218,"phoneExt":70,"email":70},"215-706-2034",{"facility":220,"status":113,"city":221,"state":222,"zip":223,"country":224,"countryCode":225,"cosmosGeoPoint":226,"geoPoint":230,"contacts":231},"Centro de Estudios Clínicos SAGA ( Site 0162)","Santiago","Region M. de Santiago","7500653","Chile","CL",{"type":120,"coordinates":227},[228,229],-70.64827,-33.45694,{"lat":229,"lon":228},[232],{"name":127,"role":107,"phone":233,"phoneExt":70,"email":70},"+56991612199",{"facility":235,"status":113,"city":221,"state":222,"zip":236,"country":224,"countryCode":225,"cosmosGeoPoint":237,"geoPoint":239,"contacts":240},"FALP ( Site 0161)","7500921",{"type":120,"coordinates":238},[228,229],{"lat":229,"lon":228},[241],{"name":127,"role":107,"phone":242,"phoneExt":70,"email":70},"+56224205098",{"facility":244,"status":113,"city":221,"state":222,"zip":245,"country":224,"countryCode":225,"cosmosGeoPoint":246,"geoPoint":248,"contacts":249},"Bradfordhill ( Site 0160)","8420383",{"type":120,"coordinates":247},[228,229],{"lat":229,"lon":228},[250],{"name":127,"role":107,"phone":251,"phoneExt":70,"email":70},"+56229490970",{"facility":253,"status":113,"city":254,"state":255,"zip":256,"country":257,"countryCode":258,"cosmosGeoPoint":259,"geoPoint":263,"contacts":264},"Alexandra General Hospital of Athens Oncology-Hematology Unit ( Site 0203)","Athens","Attica","115 28","Greece","GR",{"type":120,"coordinates":260},[261,262],23.72784,37.98376,{"lat":262,"lon":261},[265],{"name":127,"role":107,"phone":266,"phoneExt":70,"email":70},"0030 2132142545",{"facility":268,"status":113,"city":254,"state":255,"zip":269,"country":257,"countryCode":258,"cosmosGeoPoint":270,"geoPoint":272,"contacts":273},"ATTIKON GENERAL UNIVERSITY HOSPITAL-Oncology ( Site 0202)","12462",{"type":120,"coordinates":271},[261,262],{"lat":262,"lon":261},[274],{"name":127,"role":107,"phone":275,"phoneExt":70,"email":70},"0030 2313301848",{"facility":277,"status":113,"city":254,"state":255,"zip":278,"country":257,"countryCode":258,"cosmosGeoPoint":279,"geoPoint":281,"contacts":282},"Metropolitan Hospital-4th Oncology Dept ( Site 0201)","185 47",{"type":120,"coordinates":280},[261,262],{"lat":262,"lon":261},[283],{"name":127,"role":107,"phone":284,"phoneExt":70,"email":70},"0030 2104807106",{"facility":286,"status":113,"city":287,"state":288,"zip":289,"country":257,"countryCode":258,"cosmosGeoPoint":290,"geoPoint":294,"contacts":295},"University General Hospital of Heraklion ( Site 0200)","Heraklion","Irakleio","71110",{"type":120,"coordinates":291},[292,293],25.14341,35.32787,{"lat":293,"lon":292},[296],{"name":127,"role":107,"phone":297,"phoneExt":70,"email":70},"0030 2810392091",{"facility":299,"status":113,"city":300,"state":301,"zip":302,"country":303,"countryCode":304,"cosmosGeoPoint":305,"geoPoint":309,"contacts":310},"Petz Aladar Egyetemi Oktato Korhaz-Pulmonológia (Dr. Szalai Zsuzsanna) ( Site 0062)","Győr","Győr-Moson-Sopron","9024","Hungary","HU",{"type":120,"coordinates":306},[307,308],17.63512,47.68333,{"lat":308,"lon":307},[311],{"name":127,"role":107,"phone":312,"phoneExt":70,"email":70},"+3696507900",{"facility":314,"status":113,"city":315,"state":316,"zip":317,"country":303,"countryCode":304,"cosmosGeoPoint":318,"geoPoint":322,"contacts":323},"Jász-Nagykun-Szolnok Vármegyei Hetényi Géza Kórház-Onkologiai Kozpont ( Site 0061)","Szolnok","Jász-Nagykun-Szolnok","5000",{"type":120,"coordinates":319},[320,321],20.19835,47.18066,{"lat":321,"lon":320},[324],{"name":127,"role":107,"phone":325,"phoneExt":70,"email":70},"+3656503603",{"facility":327,"status":113,"city":328,"state":70,"zip":329,"country":303,"countryCode":304,"cosmosGeoPoint":330,"geoPoint":334,"contacts":335},"Országos Korányi Pulmonológiai Intézet ( Site 0060)","Budapest","1121",{"type":120,"coordinates":331},[332,333],19.04045,47.49835,{"lat":333,"lon":332},[336],{"name":127,"role":107,"phone":337,"phoneExt":70,"email":70},"+3613913200",{"facility":339,"status":113,"city":340,"state":341,"zip":342,"country":343,"countryCode":344,"cosmosGeoPoint":345,"geoPoint":349,"contacts":350},"Azienda Ospedaliera Universitaria Careggi ( Site 0173)","Florence","Tuscany","50134","Italy","IT",{"type":120,"coordinates":346},[347,348],11.24626,43.77925,{"lat":348,"lon":347},[351],{"name":127,"role":107,"phone":352,"phoneExt":70,"email":70},"+393209225506",{"facility":354,"status":113,"city":355,"state":70,"zip":356,"country":343,"countryCode":344,"cosmosGeoPoint":357,"geoPoint":361,"contacts":362},"Ospedale San Raffaele. ( Site 0171)","Milan","20132",{"type":120,"coordinates":358},[359,360],12.59836,42.78235,{"lat":360,"lon":359},[363],{"name":127,"role":107,"phone":364,"phoneExt":70,"email":70},"390223903829",{"facility":366,"status":113,"city":355,"state":70,"zip":367,"country":343,"countryCode":344,"cosmosGeoPoint":368,"geoPoint":370,"contacts":371},"Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 0175)","20133",{"type":120,"coordinates":369},[359,360],{"lat":360,"lon":359},[372],{"name":127,"role":107,"phone":373,"phoneExt":70,"email":70},"390223902190",{"facility":375,"status":113,"city":376,"state":70,"zip":377,"country":343,"countryCode":344,"cosmosGeoPoint":378,"geoPoint":382,"contacts":383},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 0174)","Roma","00168",{"type":120,"coordinates":379},[380,381],11.10642,44.99364,{"lat":381,"lon":380},[384],{"name":127,"role":107,"phone":385,"phoneExt":70,"email":70},"+390630154844",{"facility":387,"status":113,"city":388,"state":389,"zip":390,"country":391,"countryCode":392,"cosmosGeoPoint":393,"geoPoint":397,"contacts":398},"Wielkopolskie Centrum Pulmonologii i Torakochirurgii-Oddzial Onkologii Klinicznej z Pododdzialem Dz ( Site 0153)","Poznan","Greater Poland Voivodeship","60-569","Poland","PL",{"type":120,"coordinates":394},[395,396],16.92993,52.40692,{"lat":396,"lon":395},[399],{"name":127,"role":107,"phone":400,"phoneExt":70,"email":70},"+48616654242",{"facility":402,"status":113,"city":403,"state":404,"zip":405,"country":391,"countryCode":392,"cosmosGeoPoint":406,"geoPoint":410,"contacts":411},"Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 0151)","Warsaw","Masovian Voivodeship","02-781",{"type":120,"coordinates":407},[408,409],21.01178,52.22977,{"lat":409,"lon":408},[412],{"name":127,"role":107,"phone":413,"phoneExt":70,"email":70},"48225463066",{"facility":415,"status":113,"city":416,"state":417,"zip":418,"country":391,"countryCode":392,"cosmosGeoPoint":419,"geoPoint":423,"contacts":424},"Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0150)","Gdansk","Pomeranian Voivodeship","80-952",{"type":120,"coordinates":420},[421,422],18.64912,54.35227,{"lat":422,"lon":421},[425],{"name":127,"role":107,"phone":426,"phoneExt":70,"email":70},"+48 58 584 44 66",{"facility":428,"status":113,"city":429,"state":70,"zip":430,"country":431,"countryCode":432,"cosmosGeoPoint":433,"geoPoint":437,"contacts":438},"Hospital Clinic de Barcelona ( Site 0092)","Barcelona","08008","Spain","ES",{"type":120,"coordinates":434},[435,436],2.15899,41.38879,{"lat":436,"lon":435},[439],{"name":127,"role":107,"phone":440,"phoneExt":70,"email":70},"34 932275402",{"facility":442,"status":113,"city":443,"state":70,"zip":444,"country":445,"countryCode":70,"cosmosGeoPoint":446,"geoPoint":450,"contacts":451},"Baskent University Dr. Turgut Noyan Research and Training Center-ONCOLOGY ( Site 0702)","Adana","01250","Turkey (Türkiye)",{"type":120,"coordinates":447},[448,449],35.32531,36.98615,{"lat":449,"lon":448},[452],{"name":127,"role":107,"phone":453,"phoneExt":70,"email":70},"903223272727",{"facility":455,"status":113,"city":456,"state":70,"zip":457,"country":445,"countryCode":70,"cosmosGeoPoint":458,"geoPoint":462,"contacts":463},"Hacettepe Universite Hastaneleri-oncology hospital ( Site 0700)","Ankara","06230",{"type":120,"coordinates":459},[460,461],32.85427,39.91987,{"lat":461,"lon":460},[464],{"name":127,"role":107,"phone":465,"phoneExt":70,"email":70},"+903123052941",{"facility":467,"status":113,"city":468,"state":70,"zip":469,"country":445,"countryCode":70,"cosmosGeoPoint":470,"geoPoint":474,"contacts":475},"Akdeniz Universitesi Hastanesi-Medical Oncology ( Site 0704)","Antalya","07059",{"type":120,"coordinates":471},[472,473],30.69556,36.90812,{"lat":473,"lon":472},[476],{"name":127,"role":107,"phone":477,"phoneExt":70,"email":70},"902422271736",{"facility":479,"status":113,"city":480,"state":70,"zip":481,"country":445,"countryCode":70,"cosmosGeoPoint":482,"geoPoint":486,"contacts":487},"İzmir Suat Seren Chest Disease Training & Research Hospital ( Site 0701)","Izmir","35110",{"type":120,"coordinates":483},[484,485],27.13838,38.41273,{"lat":485,"lon":484},[488],{"name":127,"role":107,"phone":489,"phoneExt":70,"email":70},"902324587262",{"facility":491,"status":113,"city":492,"state":70,"zip":493,"country":445,"countryCode":70,"cosmosGeoPoint":494,"geoPoint":498,"contacts":499},"Ondokuz Mayıs Universitesi-Oncology department ( Site 0706)","Samsun","55139",{"type":120,"coordinates":495},[496,497],36.3361,41.27976,{"lat":497,"lon":496},[500],{"name":127,"role":107,"phone":501,"phoneExt":70,"email":70},"903624576041",{"facility":503,"status":113,"city":504,"state":505,"zip":506,"country":507,"countryCode":508,"cosmosGeoPoint":509,"geoPoint":513,"contacts":514},"CNE CC of Oncology Hematol ( Site 0130)","Cherkasy","Cherkasy Oblast","18009","Ukraine","UA",{"type":120,"coordinates":510},[511,512],32.05738,49.44452,{"lat":512,"lon":511},[515],{"name":127,"role":107,"phone":516,"phoneExt":70,"email":70},"+38(0472)31-94-18",{"facility":518,"status":113,"city":519,"state":520,"zip":521,"country":507,"countryCode":508,"cosmosGeoPoint":522,"geoPoint":526,"contacts":527},"Municipal Enterprise \"Bukovinian сlinical oncology сenter\" ( Site 0139)","Chernivtsi","Chernivetska Oblast","58013",{"type":120,"coordinates":523},[524,525],25.93241,48.29045,{"lat":525,"lon":524},[528],{"name":127,"role":107,"phone":529,"phoneExt":70,"email":70},"+380955077568",{"facility":531,"status":113,"city":532,"state":533,"zip":534,"country":507,"countryCode":508,"cosmosGeoPoint":535,"geoPoint":539,"contacts":540},"CNCE Precarpathian Clinical Oncologic Center ( Site 0131)","Ivano-Frankivsk","Ivano-Frankivsk Oblast","76018",{"type":120,"coordinates":536},[537,538],24.71248,48.92312,{"lat":538,"lon":537},[541],{"name":127,"role":107,"phone":542,"phoneExt":70,"email":70},"+380978411455",{"facility":544,"status":113,"city":545,"state":546,"zip":547,"country":507,"countryCode":508,"cosmosGeoPoint":548,"geoPoint":552,"contacts":553},"MNPE LTMU Multidisc. Clin. Hosp. of Emerg. and Intens. Care ( Site 0132)","Lviv","Lviv Oblast","79059",{"type":120,"coordinates":549},[550,551],24.02324,49.83826,{"lat":551,"lon":550},[554],{"name":127,"role":107,"phone":555,"phoneExt":70,"email":70},"380977453295",{"facility":557,"status":113,"city":558,"state":559,"zip":560,"country":507,"countryCode":508,"cosmosGeoPoint":561,"geoPoint":565,"contacts":566},"ME RIVNE REGIONAL ANTITUMOR CENTER ( Site 0460)","Rivne","Rivne Oblast","33010",{"type":120,"coordinates":562},[563,564],26.23695,50.62036,{"lat":564,"lon":563},[567],{"name":127,"role":107,"phone":568,"phoneExt":70,"email":70},"380503802915",{"facility":570,"status":113,"city":571,"state":572,"zip":573,"country":507,"countryCode":508,"cosmosGeoPoint":574,"geoPoint":578,"contacts":579},"Communal Noncommercial Enterprise \"Podillia Regional Oncology Center Of Vinnytsia Regional Council\" ( Site 0135)","Vinnytsia","Vinnytsia Oblast","21029",{"type":120,"coordinates":575},[576,577],28.46871,49.2322,{"lat":577,"lon":576},[580],{"name":127,"role":107,"phone":581,"phoneExt":70,"email":70},"0988936318",{"facility":583,"status":113,"city":584,"state":70,"zip":585,"country":507,"countryCode":508,"cosmosGeoPoint":586,"geoPoint":590,"contacts":591},"Shalimov Institute of Surgery and Transplantation ( Site 0138)","Kyiv","03126",{"type":120,"coordinates":587},[588,589],30.5238,50.45466,{"lat":589,"lon":588},[592],{"name":127,"role":107,"phone":593,"phoneExt":70,"email":70},"093 33 33 911",{"type":595,"investigatorFullName":70,"investigatorTitle":70,"investigatorAffiliation":70,"oldNameTitle":70,"oldOrganization":70},"SPONSOR","100576716","phase-2-pembrolizumab-mk-3475-plus-investigational-agents-in-resectable-non-small-cell-lung-cancer-nsclc-mk-3475-01ekeymaker-u01-100576716",false,"NCT06788912","Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E\u002FKEYMAKER-U01)","KEYMAKER-U01 Substudy 01E: A Phase 2 Umbrella Study With Rolling Arms of Investigational Agents With or Without Chemotherapy in Combination With Pembrolizumab in Treatment of Participants With Newly Diagnosed Resectable Stages II-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)","The main inclusion and exclusion criteria include but are not limited to the following:\n\nInclusion Criteria:\n\n* Has previously untreated and pathologically confirmed resectable Stage II, IIIA, or IIIB (N2) non-small cell lung cancer (NSCLC)\n* Able to undergo protocol therapy, including necessary surgery\n* Confirmation that epidermal growth factor receptor (EGFR) -directed therapy is not indicated as primary therapy\n* Has an Eastern Cooperative Oncology Group (ECOG) performance status of either 0 or 1 as assessed within 10 days before initiation of study intervention.\n* Is able to provide archival or newly obtained core\u002Fexcisional biopsy of the primary lung tumor or lymph node metastasis.\n\nExclusion Criteria:\n\n* Has one of the following tumor locations\u002Ftypes: NSCLC involving the superior sulcus, large-cell neuro-endocrine cancer, mixed tumors containing small cell and non-small cell elements, or sarcomatoid tumor.\n* Has Grade ≥2 peripheral neuropathy.\n* Has history of documented severe dry eye syndrome, severe Meibomian gland disease and\u002For blepharitis, or severe corneal disease that prevents\u002Fdelays corneal healing.\n* Has active inflammatory bowel disease requiring immunosuppressive medication or previous history of inflammatory bowel disease (eg, Crohn's disease, ulcerative colitis, or chronic diarrhea).\n* Has uncontrolled, significant cardiovascular disease or cerebrovascular disease.\n* Received a live or live-attenuated vaccine within 30 days before the first dose of study intervention\n* Received prior radiotherapy within 2 weeks of start of study intervention, or radiation related toxicities, requiring corticosteroids.\n* Diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (in dosing exceeding 10 mg daily of prednisone equivalent) or any other form of immunosuppressive therapy within 7 days prior to the first dose of study intervention.\n* Known additional malignancy that is progressing or has required active treatment within the past 5 years.\n* Severe hypersensitivity (≥Grade 3) to pembrolizumab and\u002For any of its excipients.\n* Active autoimmune disease that has required systemic treatment in the past 2 years. Replacement therapy (e.g. thyroxine, insulin, or physiologic corticosteroid) is allowed.\n* History of (noninfectious) pneumonitis\u002Finterstitial lung disease that required steroids or has current pneumonitis\u002Finterstitial lung disease.\n* Active infection requiring systemic therapy.\n* Hepatitis B (defined as hepatitis B surface antigen \\[HBsAg\\] reactive) or Hepatitis C virus (defined as detectable hepatitis C virus (HCV) ribonucleic acid (RNA) \\[qualitative\\]) infection.\n* Known history of human immunodeficiency virus (HIV) infection.\n* History of allogeneic tissue\u002Fsolid organ transplant.","ALL","18 Years",{"count":606,"type":607},60,"ESTIMATED","INTERVENTIONAL",[610],"PHASE2","The main goals are after treatment given before surgery, to measure the number of people who have no signs of cancer cells in tumors and lymph nodes removed during surgery; and to learn about whether the cancer gets smaller or goes away by measuring the number of people with a certain number of living cancer cells in the tumor removed during surgery.",[613],"Lung Neoplasm Malignant",[615,616,617],"Programmed Cell Death-1 (PD1, PD-1)","Programmed Cell Death 1 Ligand 1(PDL1, PD-L1)","Programmed Cell Death 1 Ligand 2 (PDL2, PD-L2)","2026-06-25",{"date":620,"type":621},"2026-06-26","ACTUAL",{"date":623,"type":621},"2025-03-20",{"date":625,"type":607},"2032-02-06",{"name":5,"class":6},38]